CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 8, 2023 · earnings

ACRS earnings: a negative outcome, -6.5%

On May 8, 2023, Aclaris Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.5% in the window around the event.

The move

$8.98
1d before
$8.40
Event day
$8.28
1d after
$7.89
5d after

Pre-catalyst setup

-1.5%
30-day run-up
5212%
30-day volatility
0.9×
volume spike